Green Mountain Coffee Roasters (NASDAQ:GMCR): Longbow sees positive trends continuing, and notes that K-Cup list prices held firm in May as private label penetration has been limited.
Harley-Davidson (NYSE:HOG): UBS believes Harley-Davidson’s April U.S. retail sales are down about 10 percent at the dealer level, which is lower than expected. Colder weather played a significant role in the decline, and the firm expects sales to trend upwards in May. It rates the shares at Neutral.
Endo Health (NASDAQ:ENDP): Cantor believes that long-acting injectable testosterone drug, Aveed, could be approved in early 2014 after Endo received a complete response letter from the FDA. Cantor notes that the agency requested only additional documentation, not additional data on the drug, though the firm thinks the drug could reach the market in the middle of next year. Still, it reiterates a Hold rating on the stock.
Priceline.com (NASDAQ:PCLN): Ascendiant expects priceline.com’s high growth and strong momentum to continue throughout 2013, and has accordingly raised its price target from $875 to $975. The firm remains positive on the company’s acquisition of KAYAK, and keeps a Buy rating on the stock.
Don’t Miss: Here’s the McDonald’s Way to Losing Weight.